Jiayin Gr (NASDAQ:JFIN) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $0.34 by 47.06 percent. This is a 100 percent increase over earnings of $0.09 per share from the same
Companies Reporting Before The Bell
• Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.
Jiayin Gr (NASDAQ:JFIN) is set to give its latest quarterly earnings report on Thursday, 2022-08-18. Here's what investors need to know before the announcement.
Analysts estimate that Jiayin Gr will report an earnings per share (EPS) of $0.34.